Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
CALL
Box
BOX
$4.52B
| $7.58M | ﹤0.01% |
301,400
-157,200
| -34% | -$4.39M |
|
2977
CALL
State Street
STT
$52.7B
| $7.58M | ﹤0.01% |
122,900
-19,700
| -14% | -$1.39M |
|
2978
CALL
iShares Core S&P Total US Stock Market ETF
ITOT
$98.3B
| $7.57M | ﹤0.01% |
90,400
+41,200
| +84% | +$3.75M |
|
|
FMTX
2979
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $7.56M | ﹤0.01% |
1,097,744
+677,615
| +161% | +$4.76M |
|
2980
CALL
Ternium
TX
$10.6B
| $7.55M | ﹤0.01% |
209,300
-173,200
| -45% | -$7.36M |
|
|
DBTX
2981
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $7.55M | ﹤0.01% |
1,792,308
+18,617
| +1% | +$44K |
|
2982
CALL
CBRE Group
CBRE
$44.3B
| $7.54M | ﹤0.01% |
102,500
+9,900
| +11% | +$797K |
|
2983
PUT
Knight Transportation
KNX
$11.8B
| $7.54M | ﹤0.01% |
163,000
-26,400
| -14% | -$1.25M |
|
|
CCXI
2984
DELISTED
ChemoCentryx, Inc.
CCXI
| $7.54M | ﹤0.01% |
304,424
-1,906
| -0.6% | -$42K |
|
2985
Stellantis
STLA
$20.2B
| $7.54M | ﹤0.01% |
609,703
+10,323
| +2% | +$146K |
|
2986
PUT
Viatris
VTRS
$18.6B
| $7.53M | ﹤0.01% |
719,096
-295,820
| -29% | -$3.24M |
|
2987
CALL
Teradata
TDC
$2.57B
| $7.53M | ﹤0.01% |
203,400
-122,000
| -37% | -$4.87M |
|
|
LTC
2988
LTC Properties
LTC
$2.17B
| $7.52M | ﹤0.01% |
195,773
+53,576
| +38% | +$1.98M |
|
2989
Pinnacle Financial Partners Inc
PNFP
$16.3B
| $7.52M | ﹤0.01% |
103,936
+35,309
| +51% | +$2.79M |
|
2990
Universal Health Services
UHS
$10B
| $7.51M | ﹤0.01% |
74,619
+9,759
| +15% | +$1.22M |
|
|
JUGG
2991
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
| $7.51M | ﹤0.01% |
770,342
-700,020
| -48% | -$6.82M |
|
2992
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $7.51M | ﹤0.01% |
215,800
+168,800
| +359% | +$6.44M |
|
2993
Power Integrations
POWI
$3.51B
| $7.49M | ﹤0.01% |
99,918
-71,647
| -42% | -$5.81M |
|
2994
Werner Enterprises
WERN
$2.33B
| $7.49M | ﹤0.01% |
194,444
-216,601
| -53% | -$8.53M |
|
|
2995
CALL
Universal Health Services
UHS
$10B
| $7.49M | ﹤0.01% |
74,400
+9,400
| +14% | +$1.18M |
|
2996
PUT
Ovintiv
OVV
$17.4B
| $7.49M | ﹤0.01% |
169,500
+38,400
| +29% | +$1.98M |
|
2997
PureCycle Technologies
PCT
$1.4B
| $7.49M | ﹤0.01% |
1,009,434
+820,142
| +433% | +$6.87M |
|
|
JPXN
2998
iShares JPX-Nikkei 400 ETF
JPXN
$142M
| $7.49M | ﹤0.01% |
132,878
+16,866
| +15% | +$1.01M |
|
2999
CALL
Kimbell Royalty Partners
KRP
$1.52B
| $7.48M | ﹤0.01% |
477,000
+154,400
| +48% | +$2.69M |
|
|
PMGM
3000
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
| $7.48M | ﹤0.01% |
753,898
+218
| +0% | +$2.16K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.